Status:
TERMINATED
Predictors of AAA Expansion and/or Rupture
Lead Sponsor:
Washington University School of Medicine
Conditions:
Abdominal Aortic Aneurysm (AAA)
Eligibility:
All Genders
45+ years
Phase:
PHASE4
Brief Summary
Eligible subjects in this study will have either a known abdominal aortic aneurysm (AAA) or because they do not have an AAA (control group). The purpose of this research study is to further study, th...
Detailed Description
Eligible subjects in this study will have either a known abdominal aortic aneurysm (AAA) or because they do not have an AAA (control group). The aorta serves as the main artery to supply blood flow t...
Eligibility Criteria
Inclusion
- Inclusion
- All ethnic groups
- 45 years of age or older
- \*Must fit into one of the three following groups:
- Control group (atherosclerosis without aneurysmal disease
- Small AAA (3-4.5 cm)
- Rapidly growing AAA (0.5 cm in 6 months or 1 cm in 12 months)
- Exclusion
- At risk population (cognitively impaired)
- Any exclusion for PT-CT (i.e., allergy to contrast)
- Any woman planning to become pregnant, suspects pregnancy, pregnant or breastfeeding)
- Any greater than normal potential for cardiac arrest
- Renal disease (eGFR \<60 mg/ml/1.73m2)
- Claustrophobic reactions and/or is unable to lie on the exam table for 60 minutes
- Significant radiation exposure via other trials or medical testing
Exclusion
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03231397
Start Date
August 1 2017
End Date
April 30 2020
Last Update
July 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110